Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver β-catenin and vascular endothelial growth factor expression

doi:10.3748/wjg.v25.i25.3196

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5202)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

307

WORD

163

HTML

2553

Figures (1-8)

181

Tables (1-1)

159

Sum=3363

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

642

Download

1197

Sum=1839

Jul 7, 2019 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jul 7, 2019; 25(25): 3196-3206
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3196

Full Size Figure Download Figure

Figure 5 Immunohistochemical staining for vascular endothelial growth factor and β-catenin in the liver of nude mice after sporamin treatment. Photomicrographs of liver sections from the control group (A), vehicle group (B), and sporamin group (C). Magnification, 40×. VEGF: Vascular endothelial growth factor.

Citation: Yang C, Zhang JJ, Zhang XP, Xiao R, Li PG. Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver β-catenin and vascular endothelial growth factor expression. World J Gastroenterol 2019; 25(25): 3196-3206
URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3196.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i25.3196